Related Experiment Video
Updated: Jun 5, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Sex-dimorphic tumor growth is regulated by tumor microenvironmental and systemic signals
Xianfeng Wang1, Hongcun Bao1, Yi-Chun Huang1
1Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, Louisiana Cancer Research Center, New Orleans, LA 70112, USA.
Abstract:
Tumor growth and progression involve coordinated regulation by internal, microenvironmental, and systemic signals and often display conspicuous sexual dimorphism. The mechanisms governing the integration and coordination of these signals, along with their sex-based differences, remain largely unknown. Using a Drosophila tumor model originating from nonreproductive tissue, we show that female-biased tumor growth involves multifaceted communications among tumor cells, hemocytes, and neuroendocrine insulin-producing cells (IPCs). Notch-active tumor cells recruit hemocytes carrying the tumor necrosis factor-α (TNF-α) homolog Eiger to the tumor microenvironment (TME), activating the c-Jun N-terminal kinase (JNK) pathway in tumor cells, instigating the sexually dimorphic up-regulation of cytokine Unpaired 2 (Upd2). Upd2, in turn, exerts a distal influence by modulating the release of a Drosophila insulin-like peptide (Dilp2) from IPCs. Dilp2 then activates the insulin signaling in the tumor, thereby fostering sexual-dimorphic tumor growth. Together, these findings reveal a relay mechanism involving the TME and systemic signals that collectively control the sexual dimorphism of tumor growth.
Insights
Female fruit flies show faster tumor growth due to complex communication between tumor cells, immune cells, and insulin-producing cells. This interaction involves specific signaling pathways that regulate growth differently between sexes.
Area of Science:
- Developmental Biology
- Cancer Biology
- Endocrinology
Background:
- Tumor growth is regulated by complex signals, with notable sex-based differences.
- Mechanisms underlying tumor signal integration and sexual dimorphism are poorly understood.
Purpose of the Study:
- To investigate the mechanisms controlling sexually dimorphic tumor growth.
- To elucidate the communication pathways between tumor cells, immune cells, and endocrine cells in a Drosophila model.
Main Methods:
- Utilized a Drosophila tumor model derived from non-reproductive tissue.
- Analyzed intercellular communication involving Notch, TNF-α homolog Eiger, JNK pathway, cytokine Upd2, and Drosophila insulin-like peptide 2 (Dilp2).
Main Results:
- Female-biased tumor growth was observed, driven by tumor cell-hemocyte-IPC interactions.
- Notch-active tumor cells recruit hemocytes, leading to JNK activation and Upd2 up-regulation.
- Upd2 modulates Dilp2 release, which activates insulin signaling, promoting sex-specific tumor growth.
Conclusions:
- A novel relay mechanism involving the tumor microenvironment and systemic signals controls tumor growth sexual dimorphism.
- This study reveals a complex interplay of signaling pathways contributing to sex-based differences in tumor progression.
More Related Videos
06:36A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion
Published on: April 24, 2015
09:42Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis
Published on: June 26, 2019
Related Concept Videos
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply
Abnormal Proliferation